ArticleJournal for immunotherapy of cancer2022

NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.

Mikiya Ishihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.